Navigation Links
New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
Date:3/19/2008

ty that couldn't be further from the truth," she says. "Health care professionals need to be aware of the role that physical therapists play in treating incontinence so that their patients know about alternatives to diapers, medication, or surgery."

Jenkyns notes that physical therapists use a variety of methods to help patients correct pelvic floor dysfunction. The initial patient evaluation requires determining the type of incontinence (stress, urge, or both), the extent of incontinence, assessing the strength, motor control and endurance of pelvic floor muscles, and screening for any other musculoskeletal issues, then developing an individualized exercise treatment program, and making sure patients understand their role in the treatment program.

In a case study published in the New England Journal of Medicine (March 6, 2008) regarding urinary incontinence in women, it is noted that "first-line treatment for stress incontinence includes pelvic floor muscle training." Affirming the Annals of Internal Medicine results, this second study points out that women unable to identify their pelvic floor muscles "may benefit from seeing a physical therapist trained in pelvic floor therapy."

Kegel exercises, or pelvic floor muscle exercises that involve contracting, holding, and releasing pelvic floor muscles, are the most effective weapon in the fight against stress incontinence. "Once patients have correctly identified these muscles, a physical therapist will train how to enhance pelvic floor muscle function, coordinate with abdominal muscle exercises and bring these exercises and awareness into functional activities," says Jenkyns. She notes that these exercises need to be brought into daily activities, and can be done when sitting at your desk or on the toilet, while driving, or at the gym. For those with very weak muscles, she recommends starting the exercises while lying down.

Jenkyns always reminds her patients who experience stress
'/>"/>

SOURCE American Physical Therapy Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...wire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin B...nown as DOR BioPharma, Inc., a late-stage biotechn...a consortium to develop thermostable technology to...es. Soligenix received a $9.4 million grant from t...seases (NIAID), a division of the National Institu...
(Date:11/19/2009)...wire-FirstCall/ -- In a series of new initiatives ...ation (Nasdaq: HSKA ) ("Heska" or the "Company") ... website. The upgraded site is the result of seve...align the site with the company,s new brand image ...ww.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,...
(Date:11/19/2009)...swire-FirstCall/ -- The D e al magazine has na...ed Corporate Dealmakers for the second consecutive...red Dealmaker in pharma/biotech for the most effec...s since January 2006. ,, Over the past decade, ...focus on high-growth, innovation-driven businesses...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 1New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 2Compound Targets Destroys Cancer Stem Cells in Mice 54494 1Compound Targets Destroys Cancer Stem Cells in Mice 54494 2Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 1Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 2Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 3Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 4Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 5Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 6Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 7Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 8Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 9
... 2008 Annual Financial Guidance, DUBLIN, Calif., ...ical company dedicated to the discovery, rapid,dev...lid tumors and,hematological malignancies, today c...rial, initiated in 2002, comparing Dacogen(R) (dec...C) in elderly patients with,myelodysplastic syndro...
... July 1 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX...ts from its,discontinued Phase 3 clinical trial of...biomodulator of 5-FU (5 fluorouracil), for the tre... The primary endpoint of the study,was progression... reported,by the Company along with safety data la...
Other Medicine Technology:SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 2ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 3ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 4
(Date:11/22/2009)... under control, expert says , , SUNDAY, ...ns you,ll be faced with a seemingly endless buffet... in and eat too much, others deny themselves any h... between overindulgence and deprivation, according...rvices at Brigham and Women,s Hospital in Boston. ...
(Date:11/21/2009)...Newswire-USNewswire/ -- Tonight, in a partisan vot...d,s version of the government takeover of health c...d in this bill; like the public option, employer a...for elective abortion, which is the most onerous a...ovides subsidies for private plans that cover elec...
(Date:11/21/2009)...Key Provisions of Legislation, Continues Push for ... Ill., Nov. 21 With t...ark Affordable Health Care for America Act (H.R. 3...slation forward, Congress has taken decisive steps...oday, AARP hosted an educational forum to discuss ...
(Date:11/21/2009)...all, president and chief executive officer of the ... following statement regarding the inclusion of co...nual wellness for Medicare beneficiaries in "...t; that was introduced last night: , ... -- Eric J. Hall, president and chief executive of...
(Date:11/20/2009)...RNewswire-USNewswire/ -- The American Academy of ...are reform legislation released this week to conta...individual coverage mandate. The actuaries said th...ize adverse selection stemming from more restricti...,, "The individual mandate language should be s...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2
... cholesterol drug no better than placebo at easing... , MONDAY, July 21 (HealthDay News) -- The con... the risk of major heart valve problems, according... was no better than placebo at lowering the odds o...
...University, the University of Cincinnati (UC) and ...are hoping to find a geographical pattern to help ...fatal neurological disease amyotrophic lateral scl...e,ve found there were some areas of service where ...
...ple have consumed cranberry juice, convinced of it...gh the exact mechanism of its action has not been ...cester Polytechnic Institute (WPI) reveals that th...g close enough to latch onto cells and initiate an...
...ls on organ,s surface, spare surrounding tissue ...tients are being recruited for a clinical trial of...l for pleural mesothelioma, a cancer of the lung,s...nd chemotherapy treatments of patients with malign...
...nopause women think that only hormones can reduce ...ol herbs can cool down hot flashes not only effect...Ann Arbor, MI (PRWEB) July 21, 2008 -- The hot sum...plicated information overwhelms menopause women. S...
...p in understanding how the nervous system and the ...n Institute for Medical Research have identified a...he spleen communicate. , ...stein Institute for Medical Research have identif...
Other Medicine News:Health News:Vytorin Fails to Lower Heart Valve Problems 2Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 2Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 3Health News:Cranberry juice creates energy barrier that keeps bacteria away from cells, study shows 2Health News:Lung Cancer Trial Targets Asbestos-Related Disease 2Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 2Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 3Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 2Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 3
MiniCycler thermal cycler
Dual-bay Dyad thermal cycler chassis
... with 24-well x 0.2ml sub-ambient block and automa...rmistor) Heating rates: up to 3C/second; Accurate ...om 4-99C; Excellent uniformity: better than 0.5C w...programming: directory program storage of up to 60...
...ycler unit is an inexpensive personal or mini ther...ess. Lightweight, with a small footprint, it can b...luding the researcher's desk. , The Gene Cycl...ho do not have access to a large laboratory therma...
Medicine Products: